Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Mitogen- and stress-activated kinases (MSK1 and MSK2)** are nuclear kinases activated by phosphorylation through ERK1/2 or p38 MAPK pathways. They phosphorylate several substrates, including the transcription factor CREB and histone H3, regulating expression of immediate early genes relevant for cellular stress response, inflammation, and neuronal plasticity. In immune cells, MSKs are important anti-inflammatory regulators, modulating the production of cytokines such as IL-10. In neurons, MSKs contribute to synaptic plasticity and cellular proliferation. MSKs are part of the MAPK-activated protein kinase family (MAPKAPK), which forms a key step in signal transmission from surface receptors to changes in gene expression.
Drugs inhibiting p38 MAPK and ERK1/2 prevent activation of MSK1/2, reducing downstream phosphorylation of CREB and histone H3. Modulation of cytokine production (e.g., enhancing anti-inflammatory IL-10, reducing TNFα, IL-6).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitogen- and stress-activated kinase 1 (and 2) (MSK1 (MSK2)).